India today launches mega rollout of coronovirus vaccine

Priority is given to vaccinations of health workers, people over 50 and people at high risk.

new Delhi:

One of the world’s largest coronavirus vaccine programs will begin in India with Prime Minister Narendra Modi launching a vaccination campaign at 10.30 am on Saturday.

The vaccination program, aimed at first vaccinating 3 million health and other frontline workers, will use shots manufactured in India – one developed by Oxford University and AstraZeneca, the other by India Biotech with the country’s top clinical research body.

Health workers, those over the age of 50 and high risk, are given priority to receive one of the two approved vaccines.

About 300,000 people will receive the first dose of two on the first day.

Officials say they are drawing on their experience with the child immunization program for the election and vaccination of polio and tuberculosis.

Here are the live updates on COVID-19 vaccination:

Coronavirus virus: Volunteer shots today for vaccine in Assam vaccine

A dozen doctors in Assam took vaccine shots earlier today at Gauhati Medical College to dispel rumors about the Kovid vaccine and to encourage their fraternity to prepare for the world’s biggest vaccination against the country’s deadly coronovirus. Has volunteered for

Assam has registered 2.9 lakh frontline healthcare workers for the first phase of the vaccination campaign, of which 1.9 lakh will be vaccinated today.

The state has received 2.21 lakh doses of Kovid vaccines so far. This includes more than 2 lakh doses of the Oxford-AstraZeneca covshield vaccine and 20,000 doses of indigenously developed Kovaxin by Bharat Biotech.

Coronavirus news: India begins vaccination today

A nationwide COVID-19 vaccination campaign by Prime Minister Narendra Modi will be launched at 10:30 am today, which marked a step towards overcoming the epidemic in India, which devastated the economy and brought unprecedented suffering in the last 12 months.

One of the world’s largest immunization programs aimed at vaccinating 30 million health and other frontline workers, it will use shots manufactured in India – one developed by Oxford University and AstraZeneca, the other by India Biotech, the country’s top clinical With the medical body.

.

LEAVE A REPLY

Please enter your comment!
Please enter your name here